Read our latest article - Rare disease clinical trials continue, thanks to new technology
Rare Disease Day offers a valuable opportunity to raise awareness of rare disease and campaign for health equity. We are ...Read more >
News
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications
Vault CTMS and Vault eTMF provide complete visibility into trials, enabling CRO to deliver value-added services to sponsors PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva ...Read more >
Simbec-Orion and Oncodistinct Network agreement to strengthen early phase oncology research
Providing oncology drug developers with the successful delivery of early phase oncology studies. Slough, Berkshire, United Kingdom: Simbec-Orion announced a ...Read more >
Exvastat wins a 3.6 million euro grant for COVID-19 trial
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. ...Read more >
Maintaining an agile and collaborative approach during the COVID-19 Pandemic
Simbec-Orion COVID-19 Update 1 April 2020
Lending a Hand to Support Rare Disease Day
As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from ...Read more >
Improving Patient Engagement In Clinical Trials To Develop New Drugs
Developing new drugs is a rigorous and detailed process, requiring close scrutiny and testing across clinical trials in order for ...Read more >
Challenges And Opportunities In Rare Disease Clinical Trials: Putting The Patient First
Clinical research helps develop new evidence-based approaches to treating health conditions, resulting in better, safer and more effective treatments. However, ...Read more >
Simbec-Orion Receives The “CRO Of The Year” Award At 2019 European Lifestars AwardsTM
Celebrating success across life sciences London, UK, November 25th 2019. Simbec-Orion is pleased to announce that it has been recognised ...Read more >